Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Urology|March 30, 1999
Paclitaxel and carboplatin in patients with metastatic transitional cell cancer of the urinary tractA Pycha, M Grbovic, B Posch, et al.
Urology|May 1, 1999
Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder: an alternative to classic prognostic indicators?A Pycha, C Mian, B Posch, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|November 25, 2003
Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion Multicolour-FISH in the detection of urothelial carcinomaC Mian, M Lodde, E Comploj, et al.
Clinical Radiology|March 5, 2017
Uric acid versus non-uric acid renal stones: in vivo differentiation with spectral CTF Lombardo, M Bonatti, G A Zamboni, et al.
World Journal of Urology|November 13, 2012
Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomyM Lodde, R Mayr, T Martini, et al.
Der Urologe. Ausg. A|November 17, 2020
[Practical skills training : How suitable is Peyton's four-step approach for residents in urology?]U Necknig, A Buchner, H Leyh, et al.
Urologia Internationalis|July 18, 2013
Validation of RiskCheck Bladder Cancer ©, version 5.0 for risk-adapted screening of bladder cancerT Martini, R Mayr, M Lodde, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2017
ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter studyI Heidegger, H Klocker, R Pichler, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2015
Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomyM Gierth, R Mayr, A Aziz, et al.
British Journal of Cancer|August 29, 2013
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderE Xylinas, M Kent, L Kluth, et al.
Pageof 6